References
- Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 156: 7–13, 24 Suppl
- Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Maki Y. Antisecretory activity of AG-1749, a proton pump inhibitor. Jpn J Pharmacol 1986; 226, 40 Suppl
- Miiller P, Dammann H G, Leucht U, Simon B. Human gastric acid secretion following repeated doses of AG-1749. Aliment Pharmacol Ther 1989; 3: 193–8
- Nagaya H, Satoh H, Kubo Maki K. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J Pharmacol Exp Ther 1989; 248: 799–805
- Satoh H, Inatomi N, Nagaya H, et al. Antisecretory and antiulcer activity of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther 1989; 248: 806–15
- Hochlaf S, Vatler J, Ruszniewski P, et al. Is lansoprazole as effective as omeprazole in patients with Zollinger-Ellison syndrome?. Gastroenterology 1991; 100: A84
- Londong W, Barth H, Dammann H G, et al. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 1991; 5: 245–54
- Licht H, Lemaire M. Lansoprazole versus ranitidine in duodenal ulcer. Gastroenterology 1991; 98: A78
- Benhaim M C, Evreux M, Salducci J, Petite J P, Lemaire M. Lansoprazole and ranitidine in treatment of reflux oesophagitis:double blind comparative trial. Gastroenterology 1990; 98: A20
- Stene-Larsen G, Weberg R, Frøyshov Larsen I, Bjørtuft Ø, Hoel B, Berstad A. Relationship of overweight to hiatus hernia and reflux oesophagitis. Scand J Gastroenterol 1988; 23: 427–32
- DeMeester T R, Ching I W, Wernley J A, et al. Technique, indications and clinical use of 24-hour esophageal pH-monitor-ing. J Thorac Cardiovasc Surg 1980; 79: 656–70
- Machin D, Campbell MJ. Statistical tables for the design of clinical trials. Blackwell Scientific Publications, London 1987
- Fleiss JL. Statistical methods for rates and proportions.2nd ed. John Wiley and Sons, London 1981
- SAS User's guide: statistics.Version 5 ed. SAS Institute, Carey, NC 1983
- SAS SUGI supplemental library user's guide. SAS Institute, Cary, NC 1983
- StatXact statistical software for exact nonparametric inference.Version 2.0. CYTEL Software Corp., Cambridge, MA 1991
- Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux oesophagitis. Scand J Gastroenterol 1988; 23: 625–32
- Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts J-L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523–9
- Zeitoun P, Rampal P, Barbier P, et al. Oméprazole (20 mg/j) comparé à ranitidine (150 mg 2 fois/j) dans le traitement de l'oesophagite par reflux. Resultats d'un essai multicentrique franco-beige, randomise en double insu. Gastroenterol Clin Biol 1989; 13: 457–62
- Dorsch E, Jones J, Padgett C, et al. Lansoprazole heals moderate to severe reflux esophagitis. Am J Gastroenterol 1991; 86: 1294